Diversify Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,533
Closed -$566K 466
2025
Q4
$566K Buy
4,533
+569
+14% +$69.1K 0.02% 568
2025
Q3
$484K Sell
3,964
-332
-8% -$37.7K 0.02% 575
2025
Q2
$516K Buy
4,296
+674
+19% +$71.7K 0.02% 524
2025
Q1
$377K Buy
3,622
+1,109
+44% +$114K 0.02% 422
2024
Q4
$226K Sell
2,513
-491
-16% -$44.2K 0.01% 563
2024
Q3
$265K Sell
3,004
-210
-7% -$16K 0.01% 529
2024
Q2
$218K Sell
3,214
-1,126
-26% -$75.1K 0.01% 589
2024
Q1
$316K Buy
+4,340
New +$334K 0.02% 527

Other funds holding GILD

Diversify Advisory Services's GILD Position: Q1 2026 in Review

Diversify Advisory Services sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 4,533 shares — an estimated $566K sold.

Diversify Advisory Services first reported a position in GILD in Q1 2024 and held it in 8 quarters. The position peaked at $566K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Diversify Advisory Services reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Diversify Advisory Services sold 4,533 Gilead Sciences shares in Q1 2026, an estimated $566K.
  • Diversify Advisory Services first reported a position in Gilead Sciences in Q1 2024 and held it in 8 quarters.
  • Diversify Advisory Services's Gilead Sciences position peaked at $566K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Diversify Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.